Metropolis launches Molecular Genomics, Superspeciality Pathology & Companion Diagnostics Centers
Introduces specialised tests for Non-Invasive Genetic Assessments for Pregnancy Management that can aid in early detection of chromosomal abnormalities Launches BRCA1/BRCA 2 Genetic testing for Hereditary Breast and Ovarian Cancer (HBOC), and Molecular Oncology pipeline for Lung and common cancers India, Chennai, 7th July 2022: In keeping with its commitment to ensure access to high quality, advanced, and cost-effective diagnostic testing for all, Metropolis Healthcare Ltd. a leading diagnostic service provider today announced the launch of Metropolis Innovation Cell focusing on Molecular Genomics, Superspeciality Pathology and Companion Diagnostics. Under Innovation Cell, Metropolis is introducing various specialized tests related to Pregnancy, Cancer, Infectious Diseases and Transplant Management. Youtube VideoЁЯСЗЁЯСЗ Commenting on the establishment of Metropolis Innovation Cell, Ms. Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Limited said, “As the Innovation and...